A Cohort Study to Determine the Incidence of Dengue Fever and to Build Capacity for Dengue Vaccine Trials in Dengue-endemic Regions of South Asia
Sponsor: GlaxoSmithKline
A NA clinical study on Dengue, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 11 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
-
Oct 2019 — Aug 2020 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 6 earlier versions
-
Jun 2019 — Oct 2019 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Active Not Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2017 — Aug 2017 [monthly]
Recruiting NA
-
Apr 2017 — May 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
- Ministry of Health, Sri Lanka
For direct contact, visit the study record on ClinicalTrials.gov .